echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Meituan enters the medical surgical robot

    Meituan enters the medical surgical robot

    • Last Update: 2021-12-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Connaught, an innovative surgical robot company, completed a round B financing of 500 million yuan.


    Why "Connaughton" was favored by Meituan

    Why "Connaughton" was favored by Meituan

    Connaught, which was "fancy" by Meituan this time, is a robotics research and development company focusing on surgery, rehabilitation and clinical treatment.


    The founder, Ou Guowei, is a Ph.


    At present, Connaught Stern has established R&D centers in Shenzhen, China, Hong Kong, and the United States, and formed a professional team of hundreds of people.


    Connaught's current round of financing is mainly used for surgical robot product research and development, clinical trials, market promotion, new product layout and industry-leading technology platform construction


    Many manufacturers compete in the surgical robot market

    Many manufacturers compete in the surgical robot market

    Medical surgical robots overcome the problems of poor accuracy of traditional surgical operations, long operation time, doctor fatigue and lack of three-dimensional precision vision, which brings better clinical outcomes to patients and greatly shortens the doctor’s learning curve for complex operations.


    On November 2, MicroPort Medical Robot was successfully listed on the Hong Kong Stock Exchange.


    In terms of products, in 2016, Tianjihang’s orthopedic surgical robot "Danji 1.


    On October 27, Shandong Weigao’s “laparoscopic endoscopic surgery equipment” was approved by the State Food and Drug Administration, becoming the first approved endoscopic surgery robot in China


    Minimally Invasive Medical Robots has currently launched three flagship products-Tumai endoscopic surgical robot, dragonfly eye three-dimensional electronic abdominal endoscopy, and Honghu orthopedic surgical robot.


    In addition, more emerging companies in the domestic surgical robot field, including the Lancet Robot and Huazhi MicroPort, have received financial support


    Summary of current domestic medical robot investment and financing events

    However, at present, the domestic surgical robot market is mainly occupied by Da Vinci surgical robots


    On the other hand, the Da Vinci surgical robot is also actively strengthening the localization of the layout to promote cost reduction.


    Medical insurance payment guides the surgical robot market

    Medical insurance payment guides the surgical robot market

    In April this year, the Shanghai Medical Insurance Bureau included 28 new items in the payment scope of Shanghai’s basic medical insurance.


    On October 23, the Beijing Medical Insurance Bureau issued the "Notice on Standardizing and Adjusting the Price of Physical Therapy and Other Medical Services", in which robot-assisted orthopedic surgery was included in the Beijing Class A medical insurance payment list, and patients can receive 100% full reimbursement


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.